On October 24, 2024, 180 Life Sciences Corp. announced the appointment of Jay Goodman to its Board of Directors, effective immediately. Goodman, with over a decade of experience in the SaaS and iGaming industries, has been appointed as a Class I director and will serve until the 2025 Annual Meeting of Stockholders. The Board has determined that Goodman is independent according to Nasdaq rules and will serve on the Nominating and Corporate Governance Committee, Audit Committee, and as Chairman of the Compensation Committee. Goodman's appointment follows the mutual termination of Blair Jordan's Offer Letter due to his new role as Interim CEO. Goodman's compensation includes an annual retainer fee of $50,000 and an additional $15,000 for his role as Chairperson of the Compensation...Show More

On October 24, 2024, 180 Life Sciences Corp. announced the appointment of Jay Goodman to its Board of Directors, effective immediately. Goodman, with over a decade of experience in the SaaS and iGaming industries, has been appointed as a Class I director and will serve until the 2025 Annual Meeting of Stockholders. The Board has determined that Goodman is independent according to Nasdaq rules and will serve on the Nominating and Corporate Governance Committee, Audit Committee, and as Chairman of the Compensation Committee. Goodman's appointment follows the mutual termination of Blair Jordan's Offer Letter due to his new role as Interim CEO. Goodman's compensation includes an annual retainer fee of $50,000 and an additional $15,000 for his role as Chairperson of the Compensation Committee, with payment options in cash, stock, or a combination of both. The company also plans to enter into a standard form of Indemnity Agreement with Goodman. His extensive background includes roles at Docker, Inc., Confluent, and Skywind Games, and he has been part of three successful IPOs. The announcement was made alongside the engagement of a Senior Technology Consultant, as part of the company's strategic expansion into the online gaming market.